Print

HVTN 505

Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men

Trial Details:

IIb Terminated
National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) July 06, 2009
VRC-HIVDNA016-00-VP,VRC-HIVADV014-00-VP DNA env A, env b, env C, gag B, pol B, nef B; Ad5 env A, env B, env C, gag B, pol B
VRC-HIVDNA016-00-VP DNA
VRC-HIVADV014-00-VP Viral Vector - Adeno
USA 2504
http://clinicaltrials.gov/show/NCT00919789?order=22